Contact us

877-469-1TRM
424-208-8866

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

A Randomized, Double-Blind, Placebo-Controlled, Study of the Saefty and Efficacy of Farletuzumab in Combination With Carboplatin and Paclitaxel or Docetaxel Followed by Pemetrexed in Chemotherapy-naive Subjects With Stage IV Adenocarcinoma of the Lung With Wild Type Epidermal Growth Factor Receptor (EGFR)

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
Adenocarcinoma of the Lung Farletuzumab II Closed